Mild cognitive impairment (MCI) is often an early warning sign of Alzheimer’s disease or dementia. Detecting MCI early can ...

Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...

As global populations age, neurological disorders such as Alzheimer's, Parkinson's, and epilepsy become more prevalent.

Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...

Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...

An innovative advance from scientists at St. Jude Children's Research Hospital is enhancing the technique's ability to check ...

Mild cognitive impairment (MCI) is an early warning sign of Alzheimer’s disease and dementia. Catching it early can make a ...

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at St. Jude Children's Research Hospital is ...

PrimeC has been given an ‘Orphan Drug’ status by the FDA (Food and Drug Administration) and EMA (European Medicines Agency).

Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology.